The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology andThe updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology and

Dr. Joseph Chang Launches Update to Bestselling Book “The Aging Myth” With 15 More Years of Breakthrough Research on Cellular Wellness

2026/02/07 03:00
Okuma süresi: 4 dk

The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology and evidence-based longevity

PROVO, Utah–(BUSINESS WIRE)–Nu Skin Enterprises Inc. (NYSE: NUS) today announced the relaunch of “The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young,” the updated edition of the bestselling book from Dr. Joseph Chang, chair of Nu Skin’s Scientific Advisory Board. The relaunch marks a significant milestone in the evolution of evidence-based beauty and wellness, bringing together decades of research that underpin Nu Skin’s science-led innovations — from ageLOC® technology to the company’s intelligent beauty and wellness platform centered on Prysm iO™.

Originally published in 2011, “The Aging Myth” challenged conventional wisdom by proving that aging isn’t about genetic destiny, but about how our genes function. It helps readers understand the science behind their healthspan, or the number of healthy years they live. As people live longer, the concept of wellness is becoming focused on the quality of health during those years. The book quickly became a hit, reaching #2 on The New York Times Best Seller List in its first week and securing the #1 spot at Barnes & Noble, and top rankings on Amazon, Borders and The Wall Street Journal best seller lists.

“The fundamental premise remains unchanged: we are not prisoners of our genetics,” said Dr. Chang. “However, the science of aging has evolved tremendously since 2011. This updated edition reflects over 15 years of additional research that continues to validate our core message: aging is biology in motion, and biology can be influenced. When wellness becomes measurable, it transforms from rhetoric into science.”

The new edition builds on the original by featuring expanded chapters on cellular resilience, oxidative stress management and the role of measurable biomarkers in health optimization. The updated content addresses how modern technology enables individuals to move beyond subjective feelings about health to objective, measurable insights about their biological age and cellular function. Dr. Chang draws from his experience guiding Nu Skin’s quarter-century commitment to evidence-driven wellness research, including breakthrough technologies like the Prysm iO intelligent wellness platform, a non-invasive skin carotenoid measurement device, which provides intelligent insights into an individual’s nutritional health.

“For years, Dr. Chang’s work has guided Nu Skin’s commitment to evidence-based innovation,” said Ryan Napierski, president and CEO. “What makes this relaunch so timely is how closely the research aligns with where Nu Skin is today as we work toward our vision to become the world’s leading intelligent beauty and wellness platform. This updated edition shows how the concepts introduced more than a decade ago have matured into a fully realized ecosystem — one where intelligent devices, targeted nutrition and personalized insights work together to support healthier aging. We believe this book provides the scientific foundation for the next decade of intelligent beauty and wellness.”

The digital edition of “The Aging Myth” is available through Amazon Kindle and other major online book retailers beginning today for $9.99.

About The Author

Joseph Y. Chang, Ph.D., was appointed chair of the Nu Skin Scientific Advisory Board in 2024. Prior to that, he served as Nu Skin’s chief scientific officer and executive vice president of product development for 18 years. A prolific author, Dr. Chang has published numerous articles, reviews and books on pharmacological research, including the New York Times best seller, The Aging Myth. With over 35 years of experience in the pharmaceutical and dietary supplement industries, Joe enjoys a comprehensive knowledge of both industries. Prior to the acquisition of Pharmanex by Nu Skin Enterprises in 1998, he served as the vice president of clinical studies and pharmacology at Pharmanex.

He has also held various research management positions at Wyeth-Ayerst, Rhone Poulenc Rorer and other biotechnology companies, where he was involved in researching natural products for arthritis and immunosuppressive treatment. He received a B.S. degree from Portsmouth University and a Ph.D. from the University of London.

About Nu Skin Enterprises Inc.

The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty and wellness device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

Contacts

Media: media@nuskin.com, (801) 345-6397
Investors: investorrelations@nuskin.com, (801) 345-3577

Piyasa Fırsatı
Mythos Logosu
Mythos Fiyatı(MYTH)
$0.006195
$0.006195$0.006195
+4.50%
USD
Mythos (MYTH) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

The post Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now? appeared on BitcoinEthereumNews.com. On the lookout for a Sector – Tech fund? Starting with Putnam Global Technology A (PGTAX – Free Report) should not be a possibility at this time. PGTAX possesses a Zacks Mutual Fund Rank of 4 (Sell), which is based on various forecasting factors like size, cost, and past performance. Objective We note that PGTAX is a Sector – Tech option, and this area is loaded with many options. Found in a wide number of industries such as semiconductors, software, internet, and networking, tech companies are everywhere. Thus, Sector – Tech mutual funds that invest in technology let investors own a stake in a notoriously volatile sector, but with a much more diversified approach. History of fund/manager Putnam Funds is based in Canton, MA, and is the manager of PGTAX. The Putnam Global Technology A made its debut in January of 2009 and PGTAX has managed to accumulate roughly $650.01 million in assets, as of the most recently available information. The fund is currently managed by Di Yao who has been in charge of the fund since December of 2012. Performance Obviously, what investors are looking for in these funds is strong performance relative to their peers. PGTAX has a 5-year annualized total return of 14.46%, and is in the middle third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 27.02%, which places it in the middle third during this time-frame. It is important to note that the product’s returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund’s [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund’s performance, it…
Paylaş
BitcoinEthereumNews2025/09/18 04:05
US-wed Irishman with no criminal record detained for months in 'traumatizing' conditions

US-wed Irishman with no criminal record detained for months in 'traumatizing' conditions

An Irish immigrant has been stuck in an ICE camp for months despite having a valid permit and no criminal record, per an interview he gave to The Irish Times, likening
Paylaş
Alternet2026/02/10 03:14
U.S. government isn’t poised to sweep in with bitcoin buys, despite Jim Cramer rumor

U.S. government isn’t poised to sweep in with bitcoin buys, despite Jim Cramer rumor

The post U.S. government isn’t poised to sweep in with bitcoin buys, despite Jim Cramer rumor appeared on BitcoinEthereumNews.com. President Donald Trump’s U.S.
Paylaş
BitcoinEthereumNews2026/02/10 03:42